Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant
potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary …

The introduction of Ki67 immunohistochemistry in the work-up of neuroendocrine neoplasms
(NENs) has opened a new approach for their diagnosis and prognostic evaluation. Since the …

Medullary thyroid carcinoma (MTC) is a neuroendocrine malignant tumor originating from
parafollicular C-cells producing calcitonin. Most of cases (75%) are sporadic while the …

Background: Medullary thyroid cancer (MTC) can be associated with significant morbidity
and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC …

Background The impact of number of node metastases versus metastatic lymph node ratio
versus AJCC node category on biochemical cure in medullary thyroid cancer (MTC) is not …

Background There remains uncertainty regarding the optimal extent of initial surgery and
management of recurrent disease in medullary thyroid cancer (MTC). We aim to describe the …

Simple Summary Peptide analogs, derived from the natural peptide hormone gastrin, are
promising candidates for improving the visualization and treatment of tumors. Gastrin …

Background: Expression of the programmed death-ligand 1 (PD-L1) in medullary thyroid
carcinoma (MTC) has been rarely reported. In this study, we evaluated PD-L1 positivity in …

The mainstay of diagnosing thyroid cancer is thyroid ultrasound with ultrasound-guided
FNB. Contrast-enhanced computed tomography and PET with [18 F]-fluorodeoxyglucose …

Medullary thyroid carcinoma (MTC) is a C-cell-derived epithelial neuroendocrine neoplasm.
With the exception of rare examples, most are well-differentiated epithelial neuroendocrine …